Surgical treatment for gastric GIST with special reference to liver metastases

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 512-516

  Maehara, Naoki ^a   Chijiiwa, Kazuo ^a   Eto, Tadaaki ^a   Funagayama, Mayumi ^a   Uchiyama, Shuichiro ^a   Nakashima, Shinya ^a   Hidaka, Hideki ^a   Hotokezaka, Masayuki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

C kit; CD34; Gastric GIST; Hepatectomy; Imatinib; Liver metastasis

Indexed keywords

IMATINIB;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK PATIENT; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; MICROWAVE THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL TIME; TOTAL STOMACH RESECTION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 44349190911     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ozguc H, Yilmazlar T, Yerci O, Soylu R, Tumay V, Filiz G, Zorluoglu A: Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J Gastrointest Surg 2005; 9:418-429.
2. Nowain A, Bhakta H, Pais S, Kanel G, Verma S: Gastrointestinal stromal tumors: Clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol 2005; 20:818-824.
3. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279:577-580.
4. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M: CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998; 11:728-734.
5. Miettinen M, Sobin LH, Lasota J: Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005; 29:52-68.
6. Sugar I, Forgacs B, Istvan G, Bognar G, Sapy Z, Ondrejka P: Gastrointestinal stromal tumors (GIST). Hepatogastroenterology 2005; 52:409-413.
7. Nishida T, Hirota S: Biological and clinical review of stromal tumors in the gastrointestinal tract: Histol Histopathol 2000; 15:1293-1301.
8. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231:51-58.
9. Ng EH, Pollock RE, Romsdahl MM: Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 1992; 69:1334-1341.
10. Mudan SS, Conlon KC, Woodruff JM, Lewis JJ, Brennen MF: Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection. Cancer 2000; 88:66-74.
11. Lang H, Nussbaum KT, Kaudel P, Fruhauf N, Flemming P, Raab R: Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg 2000; 231:500-505.
12. DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF: Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001; 234:540-548.
13. Shima Y, Horimi T, Ishikawa T, Ichikawa J, Okabayashi T, Nishioka Y, Hamada M, Shibuya Y, Ishii T, Ito M: Aggressive surgery for liver metastases from gastrointestinal stromal tumors. J Hepatobiliary Pancreat Surg 2003; 10:77-80.
14. Nunobe S, Sano T, Shimada K, Sakamoto Y, Kosuge T: Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas. Jpn J Clin Oncol 2005; 35:338-341.
15. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33:459-465.
16. Sato T, Ohyama S, Kokudo N, Suenaga M, Yamamoto J, Yamaguchi T, Muto T: The repeated hepatectomy for frequent recurrence of hepatic metastasis from gastrointestinal stromal tumor of the stomach. Hepatogastroenterology 2004; 51:181-183.
17. van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen OS: Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001; 358:1421-1423.
18. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347:472-480.
19. Scaife CL, Hunt KK, Patel SR, Benjamin RS, Burgess MA, Chen LL, Trent J, Raymond AK, Cormier JN, Pisters PW, Pollock RE, Feig BW: Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg 2003; 186:665-669.